| Baruch D Kuppermann, MD | |
|
Uci Medical Center, 101 The City Drive South, Orange, CA 92868 | |
| (714) 456-8978 | |
| Not Available |
| Full Name | Baruch D Kuppermann |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 39 Years |
| Location | Uci Medical Center, Orange, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326128455 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 000000G63254 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of California Irvine Medical Center | Orange, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California | 9830094275 | 39 |
News Archive
In this new KHN consumer column, produced in collaboration with The Washington Post, Michelle Andrews writes about high-risk pools: "If you're sick - or have ever been sick - and can't get insurance, the new health-care law promises fast relief: access to guaranteed coverage through a special federally funded insurance program starting in July.
Health information technology could improve health care quality, but it is not the cure-all solution to reducing U.S. health care costs, Congressional Budget Office Director Peter Orszag said at a forum on Friday, CQ HealthBeat reports. The forum was hosted by the Alliance for Health Reform and the Robert Wood Johnson Foundation.
The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.
People over the age of 60 are the most vulnerable to heat waves, with 82% to 92% more deaths than average occurring in this age group. Risks for heat-related illness or injury - such as heat stroke, heat exhaustion and heat cramps - are also heightened in people with obesity, heart disease, diabetes and respiratory conditions as these decrease the body's ability to adapt to temperature changes.
AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.
› Verified 9 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487602579 PECOS PAC ID: 7315841434 Enrollment ID: O20031120000945 |
News Archive
In this new KHN consumer column, produced in collaboration with The Washington Post, Michelle Andrews writes about high-risk pools: "If you're sick - or have ever been sick - and can't get insurance, the new health-care law promises fast relief: access to guaranteed coverage through a special federally funded insurance program starting in July.
Health information technology could improve health care quality, but it is not the cure-all solution to reducing U.S. health care costs, Congressional Budget Office Director Peter Orszag said at a forum on Friday, CQ HealthBeat reports. The forum was hosted by the Alliance for Health Reform and the Robert Wood Johnson Foundation.
The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.
People over the age of 60 are the most vulnerable to heat waves, with 82% to 92% more deaths than average occurring in this age group. Risks for heat-related illness or injury - such as heat stroke, heat exhaustion and heat cramps - are also heightened in people with obesity, heart disease, diabetes and respiratory conditions as these decrease the body's ability to adapt to temperature changes.
AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.
› Verified 9 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871541953 PECOS PAC ID: 9830094275 Enrollment ID: O20031126000755 |
News Archive
In this new KHN consumer column, produced in collaboration with The Washington Post, Michelle Andrews writes about high-risk pools: "If you're sick - or have ever been sick - and can't get insurance, the new health-care law promises fast relief: access to guaranteed coverage through a special federally funded insurance program starting in July.
Health information technology could improve health care quality, but it is not the cure-all solution to reducing U.S. health care costs, Congressional Budget Office Director Peter Orszag said at a forum on Friday, CQ HealthBeat reports. The forum was hosted by the Alliance for Health Reform and the Robert Wood Johnson Foundation.
The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.
People over the age of 60 are the most vulnerable to heat waves, with 82% to 92% more deaths than average occurring in this age group. Risks for heat-related illness or injury - such as heat stroke, heat exhaustion and heat cramps - are also heightened in people with obesity, heart disease, diabetes and respiratory conditions as these decrease the body's ability to adapt to temperature changes.
AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Baruch D Kuppermann, MD Uci Ophthalmology Group, Po Box 51055, Los Angeles, CA 90051-5355 Ph: (714) 456-6369 | Baruch D Kuppermann, MD Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Ph: (714) 456-8978 |
News Archive
In this new KHN consumer column, produced in collaboration with The Washington Post, Michelle Andrews writes about high-risk pools: "If you're sick - or have ever been sick - and can't get insurance, the new health-care law promises fast relief: access to guaranteed coverage through a special federally funded insurance program starting in July.
Health information technology could improve health care quality, but it is not the cure-all solution to reducing U.S. health care costs, Congressional Budget Office Director Peter Orszag said at a forum on Friday, CQ HealthBeat reports. The forum was hosted by the Alliance for Health Reform and the Robert Wood Johnson Foundation.
The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists.
People over the age of 60 are the most vulnerable to heat waves, with 82% to 92% more deaths than average occurring in this age group. Risks for heat-related illness or injury - such as heat stroke, heat exhaustion and heat cramps - are also heightened in people with obesity, heart disease, diabetes and respiratory conditions as these decrease the body's ability to adapt to temperature changes.
AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.
› Verified 9 days ago
Michael Myung-sup Han, Ophthalmology Medicare: Medicare Enrolled Practice Location: 101 The City Dr S Ste 400, Orange, CA 92868 Phone: 714-456-5691 Fax: 714-456-8874 | |
Dr. Meei-ling Tung Wu, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 991 N Tustin St, Suite 101, Orange, CA 92867 Phone: 714-639-6162 Fax: 714-639-5835 | |
Ms. Kate Chenlu Xie, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S Ste 400, Orange, CA 92868 Phone: 714-456-6693 | |
Dr. Tu Minh Tran, MD, MSC Ophthalmology Medicare: Medicare Enrolled Practice Location: 101 The City Dr S Ste 400, Orange, CA 92868 Phone: 714-456-5691 Fax: 714-456-8874 | |
Babak Fardin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-8068 Fax: 714-456-3765 | |
Dr. Laura Lucille Howard, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1031 W Chapman Ave Ste 204, Orange, CA 92868 Phone: 714-997-7000 Fax: 714-538-1142 | |
David Sami, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 392 S Glassell St Ste 100, Psf Ophthalmology, Orange, CA 92866 Phone: 714-289-2389 Fax: 714-289-2390 |